Jonas Halfvarson (J Halfvarson)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 55

Top Topics

Patients With Inflammatory Bowel Disease

Clinical Practice

Ulcerative Colitis

Endoscopic Submucosal Dissection

Top Venues

Journal of Crohn's & colitis

Alimentary pharmacology & therapeutics

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

N Lamichhane, N Melas, V Bergqvist, null null, N-P Ekholm, O Olén, J F Ludvigsson, H Hjortswang, J Marsal, C Eriksson, Jonas Halfvarson
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease. Digestive diseases and sciences 69 (6) (2024)
Samira Salihovic, Niklas Nyström, Charlotte Bache-Wiig Mathisen, Robert Kruse, Christine Olbjørn, Svend Andersen, Alexandra J Noble, Maria Dorn-Rasmussen, Igor Bazov, Gøri Perminow, Randi Opheim, Trond Espen Detlie, Gert Huppertz-Hauss, Charlotte Rose Hedin, Marie Carlson, Lena Öhman, Maria K Magnusson, Åsa V Keita, Johan D Söderholm, Mauro D'Amato, Matej Oresic, Vibeke Wewer, Jack Satsangi, Carl Mårten Lindqvist, Burisch J, Hans Holm Uhlig, Dirk Repsilber, Tuulia Hyötyläinen, Marte Lie Høivik, Jonas Halfvarson
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease. Nature communications 15 (1) (2024)
Jiangwei Sun, Jialu Yao, Ola Olén, Jonas Halfvarson, David Bergman, Fahim Ebrahimi, Bjorn Roelstraete, Annika Rosengren, Johan Sundström, Jonas F Ludvigsson
Long-term risk of myocarditis in patients with inflammatory bowel disease: a nationwide cohort study in Sweden. The American journal of gastroenterology (2024)
N Lamichhane, N Melas, V Bergqvist, null null, N-P Ekholm, O Olén, J F Ludvigsson, H Hjortswang, J Marsal, C Eriksson, Jonas Halfvarson
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease. Digestive diseases and sciences (2024)
Lucian Marinica Grando, Jonas Halfvarson, Michiel van Nieuwenhoven
Rectal Sensory and Compliance Testing: A Method Comparison Study between High-Resolution Anorectal Manometry and Barostat Investigations. Diagnostics (Basel, Switzerland) 14 (4) (2024)
Maria Ling Lundström, Christer Peterson, Charlotte Rose Hedin, Daniel Bergemalm, Maria Lampinen, Maria K Magnusson, Åsa V Keita, Robert Kruse, Carl Mårten Lindqvist, Dirk Repsilber, Mauro D'Amato, Henrik Hjortswang, Hans Strid, null null, Johan D Söderholm, Lena Öhman, Per Venge, Jonas Halfvarson, Marie Carlson
Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD. Alimentary pharmacology & therapeutics (2024)
Jiangwei Sun, Jialu Yao, Ola Olén, Jonas Halfvarson, David Bergman, Fahim Ebrahimi, Annika Rosengren, Johan Sundström, Jonas F Ludvigsson
Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. European heart journal (2024)
Jiangwei Sun, Jialu Yao, Ola Olén, Jonas Halfvarson, David Bergman, Fahim Ebrahimi, Annika Rosengren, Johan Sundström, Jonas F Ludvigsson
Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. European heart journal 45 (28) (2024)
Sarita Shrestha, Judith S Brand, Mehdi Osooli, Carl Eriksson, Ida Schoultz, Johan Askling, Tine Jess, Scott Montgomery, Ola Olén, Jonas Halfvarson
Spondyloarthritis in first-degree relatives and spouses of patients with inflammatory bowel disease: A nationwide population-based cohort study from Sweden. Journal of Crohn's & colitis (2024)
N Lamichhane, N Melas, V Bergqvist, null null, N-P Ekholm, O Olén, J F Ludvigsson, H Hjortswang, J Marsal, C Eriksson, Jonas Halfvarson
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease. Digestive diseases and sciences 69 (6) (2024)
N Lamichhane, N Melas, V Bergqvist, null null, N-P Ekholm, O Olén, J F Ludvigsson, H Hjortswang, J Marsal, C Eriksson, Jonas Halfvarson
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease. Digestive diseases and sciences 69 (6) (2024)
Sarita Shrestha, Judith S Brand, Mehdi Osooli, Carl Eriksson, Ida Schoultz, Johan Askling, Tine Jess, Scott Montgomery, Ola Olén, Jonas Halfvarson
Spondyloarthritis in First-Degree Relatives and Spouses of Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study from Sweden. Journal of Crohn's & colitis 18 (9) (2024)
N Lamichhane, N Melas, V Bergqvist, null null, N-P Ekholm, O Olén, J F Ludvigsson, H Hjortswang, J Marsal, C Eriksson, Jonas Halfvarson
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease. Digestive diseases and sciences 69 (6) (2024)
Samira Salihovic, Niklas Nyström, Charlotte Bache-Wiig Mathisen, Robert Kruse, Christine Olbjørn, Svend Andersen, Alexandra J Noble, Maria Dorn-Rasmussen, Igor Bazov, Gøri Perminow, Randi Opheim, Trond Espen Detlie, Gert Huppertz-Hauss, Charlotte Rose Hedin, Marie Carlson, Lena Öhman, Maria K Magnusson, Åsa V Keita, Johan D Söderholm, Mauro D'Amato, Matej Oresic, Vibeke Wewer, Jack Satsangi, Carl Mårten Lindqvist, Burisch J, Hans Holm Uhlig, Dirk Repsilber, Tuulia Hyötyläinen, Marte Lie Høivik, Jonas Halfvarson
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease. Nature communications 15 (1) (2024)
Samira Salihovic, Niklas Nyström, Charlotte Bache-Wiig Mathisen, Robert Kruse, Christine Olbjørn, Svend Andersen, Alexandra J Noble, Maria Dorn-Rasmussen, Igor Bazov, Gøri Perminow, Randi Opheim, Trond Espen Detlie, Gert Huppertz-Hauss, Charlotte Rose Hedin, Marie Carlson, Lena Öhman, Maria K Magnusson, Åsa V Keita, Johan D Söderholm, Mauro D'Amato, Matej Oresic, Vibeke Wewer, Jack Satsangi, Carl Mårten Lindqvist, Burisch J, Hans Holm Uhlig, Dirk Repsilber, Tuulia Hyötyläinen, Marte Lie Høivik, Jonas Halfvarson
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease. Nature communications 15 (1) (2024)
Lucian Marinica Grando, Jonas Halfvarson, Michiel van Nieuwenhoven
Rectal Sensory and Compliance Testing: A Method Comparison Study between High-Resolution Anorectal Manometry and Barostat Investigations. Diagnostics (Basel, Switzerland) 14 (4) (2024)
Sara Karlqvist, Michael C Sachs, Carl Eriksson, Dhanisha Jayesh Trivedi, Scott Montgomery, Jonas F Ludvigsson, Ola Olén, Jonas Halfvarson, null null
Comparative risk of serious infection with vedolizumab vs anti-TNF in inflammatory bowel disease: results from nationwide Swedish registers. The American journal of gastroenterology (2024)
Sara Karlqvist, Michael C Sachs, Carl Eriksson, Dhanisha Jayesh Trivedi, Scott Montgomery, Jonas F Ludvigsson, Ola Olén, Jonas Halfvarson, null null
Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease: Results From Nationwide Swedish Registers. The American journal of gastroenterology (2024)
N Lamichhane, N Melas, V Bergqvist, null null, N-P Ekholm, O Olén, J F Ludvigsson, H Hjortswang, J Marsal, C Eriksson, Jonas Halfvarson
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease. Digestive diseases and sciences 69 (6) (2024)
Jiangwei Sun, Jialu Yao, Ola Olén, Jonas Halfvarson, David Bergman, Fahim Ebrahimi, Annika Rosengren, Johan Sundström, Jonas F Ludvigsson
Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. European heart journal 45 (28) (2024)
Maria Ling Lundström, Christer Peterson, Charlotte Rose Hedin, Daniel Bergemalm, Maria Lampinen, Maria K Magnusson, Åsa V Keita, Robert Kruse, Carl Mårten Lindqvist, Dirk Repsilber, Mauro D'Amato, Henrik Hjortswang, Hans Strid, null null, Johan D Söderholm, Lena Öhman, Per Venge, Jonas Halfvarson, Marie Carlson
Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD. Alimentary pharmacology & therapeutics 60 (6) (2024)
Jiangwei Sun, Fang Fang, Ola Olén, Mingyang Song, Jonas Halfvarson, Bjorn Roelstraete, Hamed Khalili, Jonas F Ludvigsson
Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden. PLoS medicine 20 (2) (2023)
Åsa H Everhov, Jonas Söderling, Gustaf Befrits, Hamed Khalili, Gabriella Bröms, Martin Neovius, null null, Johan Askling, Jonas Halfvarson, Jonas F Ludvigsson, Ola Olén
Increasing healthcare costs in inflammatory bowel disease 2007-2020 in Sweden. Alimentary pharmacology & therapeutics (2023)
Amiko M Uchida, John J Garber, Ashley Pyne, Kathryn Peterson, Bjorn Roelstraete, Ola Olén, Jonas Halfvarson, Jonas F Ludvigsson
Eosinophilic esophagitis is associated with increased risk of later inflammatory bowel disease in a nationwide Swedish population cohort. United European gastroenterology journal (2023)
Jiangwei Sun, Bjorn Roelstraete, Emma Svennberg, Jonas Halfvarson, Johan Sundström, Anders Forss, Ola Olén, Jonas F Ludvigsson
Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study. PLoS medicine 20 (10) (2023)
Jiangwei Sun, Fang Fang, Ola Olén, Mingyang Song, Jonas Halfvarson, Bjorn Roelstraete, Hamed Khalili, Jonas F Ludvigsson
Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden. PLoS medicine 20 (2) (2023)
Jordan E Axelrad, Ola Olén, Jonas Söderling, Bjorn Roelstraete, Hamed Khalili, Mingyang Song, Adam S Faye, Michael Eberhardson, Jonas Halfvarson, Jonas F Ludvigsson
Inflammatory Bowel Disease and Risk of Colorectal Polyps: A nationwide population-based cohort study from Sweden. Journal of Crohn's & colitis (2023)
Archana Shubhakar, Bas C Jansen, Alex T Adams, Karli R Reiding, Nicholas T Ventham, Rahul Kalla, Daniel Bergemalm, Paulina A Urbanowicz, Richard A Gardner, null null, Manfred Wuhrer, Jonas Halfvarson, Jack Satsangi, Daryl L Fernandes, Daniel I R Spencer
Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease. Journal of Crohn's & colitis (2023)
Jiangwei Sun, Fang Fang, Ola Olén, Mingyang Song, Jonas Halfvarson, Bjorn Roelstraete, Hamed Khalili, Jonas F Ludvigsson
Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden. PLoS medicine 20 (2) (2023)
Jiangwei Sun, Fang Fang, Ola Olén, Mingyang Song, Jonas Halfvarson, Bjorn Roelstraete, Hamed Khalili, Jonas F Ludvigsson
Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden. PLoS medicine 20 (2) (2023)
Stefan Schreiber, Silvio Danese, Axel Dignass, Eugeni Domènech, Massimo C Fantini, Marc Ferrante, Jonas Halfvarson, Ailsa Hart, Fernando Magro, Charlie W Lees, Salvo Leone, Marieke J Pierik, Michele Peters, Polly Field, Helen Fishpool, Laurent Peyrin-Biroulet
Defining Comprehensive Disease Control for use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations. Journal of Crohn's & colitis (2023)
Jiangwei Sun, Jonas Halfvarson, Peter Appelros, David Bergman, Fahim Ebrahimi, Bjorn Roelstraete, Ola Olén, Jonas F Ludvigsson
Long-term Risk of Stroke in Patients With Inflammatory Bowel Disease: A Population-Based, Sibling-Controlled Cohort Study, 1969-2019. Neurology (2023)
Adam S Faye, Jordan E Axelrad, Jiangwei Sun, Jonas Halfvarson, Jonas Söderling, Ola Olén, Jonas F Ludvigsson
Atherosclerosis as a Risk Factor for IBD: A Population-Based Case-Control Study. The American journal of gastroenterology (2023)
Joel Thunberg, Olle Grännö, Daniel Bergemalm, Carl Eriksson, Isabella Visuri, Michael Eberhardson, Jonas Halfvarson
Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels. Scandinavian journal of gastroenterology (2023)
Ferdinando D'Amico, Virginia Solitano, Fernando Magro, Pablo Andres Olivera, Jonas Halfvarson, David T Rubin, Axel Dignass, Sameer Al Awadhi, Taku Kobayashi, Natália Souza Freitas Queiroz, Marta Calvo, Paulo Gustavo Kotze, Subrata Ghosh, Laurent Peyrin-Biroulet, Silvio Danese
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus. Journal of clinical medicine 12 (19) (2023)
Tenghao Zheng, Giulia Roda, Yamile Zabana, Celia Escudero-Hernández, Xingrong Liu, Ye Chen, Paulo Caleb Júnior Lima Santos, Ferdinando Bonfiglio, Marie-Rose Mellander, Izabella Janczewska, Lina Vigren, Klas Sjöberg, Bodil Ohlsson, Sven Almer, Jonas Halfvarson, Stephan Miehlke, Ahmed Madisch, Wolfgang Lieb, Juozas Kupčinskas, Rinse K Weersma, Luis Bujanda, Antonio Julià, Sara Marsal, Maria Esteve, Danila Guagnozzi, Fernando Fernández-Bañares, Carmen Ferrer, null null, Inga Peter, Jonas F Ludvigsson, Darrell S Pardi, Bas Verhaegh, Daisy Jonkers, Marieke J Pierik, Andreas Münch, Andre Franke, Francesca Bresso, Hamed Khalili, Jean Frederic Colombel, Mauro D'Amato
HLA signatures as pathophysiological discriminants of microscopic colitis subtypes. Journal of Crohn's & colitis (2023)
Jiangwei Sun, Fang Fang, Ola Olén, Mingyang Song, Jonas Halfvarson, Bjorn Roelstraete, Hamed Khalili, Jonas F Ludvigsson
Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden. PLoS medicine 20 (2) (2023)
Johanna Holmgren, Anna Fröborg, Isabella Visuri, Jonas Halfvarson, Henrik Hjortswang, Pontus Karling, Pär Myrelid, Ola Olén, null null, Jonas F Ludvigsson, Olof Grip
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study. Inflammatory bowel diseases (2022)
Jonas Halfvarson, Jonas F Ludvigsson, Francesca Bresso, Johan Askling, Michael C Sachs, Ola Olén
Age determines the risk of familial inflammatory bowel disease-A nationwide study. Alimentary pharmacology & therapeutics 56 (3) (2022)
Sarita Shrestha, Judith S Brand, Jacob Järås, Ida Schoultz, Scott Montgomery, Johan Askling, Jonas F Ludvigsson, Ola Olen, Jonas Halfvarson, null null
Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in Sweden. Journal of Crohn's & colitis 16 (10) (2022)
Åsa H Everhov, Rune Erichsen, Jacob Järås, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Jonas F Ludvigsson, Henrik Toft Sørensen, Ola Olén
Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study. Alimentary pharmacology & therapeutics 56 (7) (2022)
Joel Thunberg, Olle Grännö, Charlotte R H Hedin, Anders Forss, Charlotte Söderman, Daniel Bergemalm, null null, Ola Olén, Henrik Hjortswang, Hans Strid, Jonas F Ludvigsson, Carl Eriksson, Jonas Halfvarson
Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality register. United European gastroenterology journal 10 (7) (2022)
Simen Svendsen Vatn, Jonas Christoffer Lindstrøm, Aina E Fossum Moen, Stephan Brackmann, Tone M Tannæs, Christine Olbjørn, Daniel Bergemalm, Åsa V Keita, Fernando Gomollón-Bel, Trond Espen Detlie, Torben Lüders, Rahul Kalla, Alex Adams, Jack Satsangi, Prof Jørgen Jahnsen, Morten H Vatn, Jonas Halfvarson, Petr Ricanek, Hilde Nilsen, null null
Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort. Clinical and experimental gastroenterology 15 (2022)
Jonas F Ludvigsson, Jiangwei Sun, Ola Olén, Mingyang Song, Jonas Halfvarson, Bjorn Roelstraete, Hamed Khalili, Fang Fang
Normal Gastrointestinal Mucosa at Biopsy and Overall Mortality: Nationwide Population-Based Cohort Study. Clinical epidemiology 14 (2022)
Simonas Juzenas, Matthias Hübenthal, Carl Mårten Lindqvist, Robert Kruse, Tim Alexander Steiert, Frauke Degenhardt, Dominik Schulte, Susanna Nikolaus, Sebastian Zeissig, Daniel Bergemalm, Sven Almer, Henrik Hjortswang, Francesca Bresso, null null, Nina Strüning, Juozas Kupcinskas, Andreas Keller, Wolfgang Lieb, Philip Rosenstiel, Stefan Schreiber, Mauro D'Amato, Jonas Halfvarson, Georg Hemmrich-Stanisak, Andre Franke
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease. Journal of Crohn's & colitis 16 (7) (2022)
Jan Krzysztof Nowak, Alex T Adams, Rahul Kalla, Jonas C Lindstrøm, Simen Vatn, Daniel Bergemalm, Åsa V Keita, Fernando Gomollón-Bel, Jørgen Jahnsen, Morten H Vatn, Petr Ricanek, Jerzy Ostrowski, Jaroslaw Walkowiak, Jonas Halfvarson, Jack Satsangi, null null
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2. Journal of Crohn's & colitis 16 (8) (2022)
Niklas Nyström, Stefanie Prast-Nielsen, Mario Correia, Daniel Globisch, Lars Engstrand, Ina Schuppe Koistinen, Jonas Halfvarson
Mucosal and plasma metabolomes in new-onset paediatric inflammatory bowel disease: correlations with disease characteristics and plasma inflammation protein markers. Journal of Crohn's & colitis (2022)
Benita Salomon, Daniel Bergemalm, Jonas Halfvarson
Prognostic Biosignatures at Ileocecal Resection: Hope or Reality? Journal of Crohn's & colitis (2021)
Åsa H Everhov, Michael C Sachs, Jonas F Ludvigsson, Hamed Khalili, Johan Askling, Martin Neovius, Pär Myrelid, Jonas Halfvarson, Caroline Nordenvall, Jonas Söderling, Ola Olén, null null
Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn's Disease: A Population-Based Cohort Study. Clinical epidemiology 12 (2020)
HoUng Kim, Rieke E Alten, Luisa Avedano, Axel U Dignass, Fernando Gomollón, Kay Greveson, Jonas Halfvarson, Peter M Irving, Prof Jørgen Jahnsen, Péter L Lakatos, JongHyuk Lee, Souzi Makri, Ben Parker, Laurent Peyrin-Biroulet, Stefan Schreiber, Steven R A Simoens, René Westhovens, Silvio Danese, Ji Hoon Jeong
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Drugs 80 (2) (2020)
Carl Eriksson, Ida Henriksson, Ole Brus, Yaroslava Zhulina, Nils Nyhlin, Curt Tysk, Scott Montgomery, Jonas Halfvarson
Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study. Alimentary pharmacology & therapeutics 48 (6) (2018)
Jonas Halfvarson, Colin J Brislawn, Regina Lamendella, Yoshiki Vázquez-Baeza, William A Walters, Lisa M Bramer, Mauro D'Amato, Ferdinando Bonfiglio, Daniel McDonald, Antonio Gonzalez, Erin E McClure, Mitchell F Dunklebarger, Rob Knight, Janet K Jansson
Dynamics of the human gut microbiome in inflammatory bowel disease. Nature microbiology 2 (2017)
Carl Eriksson, Y Cao, S Rundquist, Y Zhulina, I Henriksson, S Montgomery, Jonas Halfvarson
Editorial: do thiopurines and biologics decrease the risk of colectomy? Authors' reply. Alimentary pharmacology & therapeutics 46 (9) (2017)
David Ellinghaus, Luke Jostins, Sarah L Spain, Adrian Cortes, Jörn Bethune, Buhm Han, Yu Rang Park, Soumya Raychaudhuri, Jennie G Pouget, Matthias Hübenthal, Trine Folseraas, Yunpeng Wang, Tõnu Esko, Andres Metspalu, Harm-Jan Westra, Lude H Franke, Tune H Pers, Rinse K Weersma, Valerie Collij, Mauro D'Amato, Jonas Halfvarson, Anders Boeck Jensen, Wolfgang Lieb, Franziska Degenhardt, Andreas J Forstner, Andrea Hofmann, null null, null null, null null, null null, null null, Stefan Schreiber, Ulrich Mrowietz, Brian D Juran, Konstantinos N Lazaridis, Søren Brunak, Anders M Dale, Richard C Trembath, Stephan Weidinger, Michael Weichenthal, Eva Ellinghaus, James T Elder, Jonathan N W N Barker, Ole Andreas Andreassen, Dermot P McGovern, Tom H Karlsen, Jeffrey C Barrett, Miles Parkes, Matthew A Brown, Andre Franke
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nature genetics 48 (5) (2016)
G Assadi, R Saleh, F Hadizadeh, L Vesterlund, F Bonfiglio, Jonas Halfvarson, L Törkvist, A S Eriksson, H E Harris, E Sundberg, M D'Amato
LACC1 polymorphisms in inflammatory bowel disease and juvenile idiopathic arthritis. Genes and immunity 17 (4) (2016)